Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Journal of Immunotoxicology
|
October 30, 2008
Changes in gene expression induced by tienilic Acid and sulfamethoxazole: testing the danger hypothesis
Stephanie R Pacitto, Jack P Uetrecht, Paul C Boutros, et al.
Nature Biotechnology
|
March 25, 2014
Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing
Adam J Shuhendler, Kanyi Pu, Lina Cui, et al.
Chemical Research in Toxicology
|
December 20, 2005
Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat
Jacintha M Shenton, Marija Popovic, Jie Chen, et al.
Chemical Research in Toxicology
|
September 19, 2006
Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats
Marija Popovic, Jeff L Caswell, Baskar Mannargudi, et al.
Chemical Research in Toxicology
|
August 16, 2005
Gene expression profiling in a model of D-penicillamine-induced autoimmunity in the Brown Norway rat: predictive value of early signs of danger
Béatrice Séguin, Paul C Boutros, Xujian Li, et al.
Chemical Research in Toxicology
|
September 16, 2003
Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat
Jacintha M Shenton, Munehiro Teranishi, Mones S Abu-Asab, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 9, 2008
Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine
Robin E Pearce, Wei Lu, Yongqiang Wang, et al.
Current Drug Safety
|
August 12, 2008
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events
Joachim Wernicke, Nayan Acharya, Indiana Strombom, et al.
Current Drug Safety
|
August 12, 2008
Hepatic effects of duloxetine-I: non-clinical and clinical trial data
Joachim Wernicke, Beth Pangallo, Fujun Wang, et al.
Nanotoxicology
|
June 7, 2024
Evaluation of the biodistribution and preliminary safety profile of a novel brain-targeted manganese dioxide-based nanotheranostic system for Alzheimer's disease
Lily Yi Li, Elliya Park, Chunsheng He, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Journal of Immunotoxicology
|
October 30, 2008
Changes in gene expression induced by tienilic Acid and sulfamethoxazole: testing the danger hypothesis
Stephanie R Pacitto, Jack P Uetrecht, Paul C Boutros, et al.
Nature Biotechnology
|
March 25, 2014
Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing
Adam J Shuhendler, Kanyi Pu, Lina Cui, et al.
Chemical Research in Toxicology
|
December 20, 2005
Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat
Jacintha M Shenton, Marija Popovic, Jie Chen, et al.
Chemical Research in Toxicology
|
September 19, 2006
Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats
Marija Popovic, Jeff L Caswell, Baskar Mannargudi, et al.
Chemical Research in Toxicology
|
August 16, 2005
Gene expression profiling in a model of D-penicillamine-induced autoimmunity in the Brown Norway rat: predictive value of early signs of danger
Béatrice Séguin, Paul C Boutros, Xujian Li, et al.
Chemical Research in Toxicology
|
September 16, 2003
Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat
Jacintha M Shenton, Munehiro Teranishi, Mones S Abu-Asab, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 9, 2008
Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine
Robin E Pearce, Wei Lu, Yongqiang Wang, et al.
Current Drug Safety
|
August 12, 2008
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events
Joachim Wernicke, Nayan Acharya, Indiana Strombom, et al.
Current Drug Safety
|
August 12, 2008
Hepatic effects of duloxetine-I: non-clinical and clinical trial data
Joachim Wernicke, Beth Pangallo, Fujun Wang, et al.
Nanotoxicology
|
June 7, 2024
Evaluation of the biodistribution and preliminary safety profile of a novel brain-targeted manganese dioxide-based nanotheranostic system for Alzheimer's disease
Lily Yi Li, Elliya Park, Chunsheng He, et al.
Page
of 4